Guest Author: Al Cardillo Executive Vice President Home Care Association (HCA) of New York State Early recognition of potential sepsis symptoms, rapid referral for confirmatory diagnosis, and swift intervention are imperative to protect patients. Healt…
Guest Author: Hallie C. Prescott, MD, MSc Pulmonary and Critical Care University of Michigan Ann Arbor VA Hospital I am an intensive care unit (ICU) doctor. Ever since I began medical training, I was drawn to the ICU. I love the challenge of caring for…
Guest Author: Jim O’Brien Vice President of Quality and Patient Safety Ohio Health Riverside Methodist Hospital I am biased about sepsis, but I will try to put that aside and present an argument for why people who have day jobs like me – hospital a…
Guest Author: Rommie L. Duckworth, LP Founder, Director New England Center for Rescue & Emergency Medicine, LLC Anya Coronel was born on April 18, 2009. A beautiful baby girl, Anya was born with spina bifida, a birth defect that, while corrected by surgery, would leave her prone to infections as well as a condition known
Guest Author: Pamela L. Popp MA JD DFASHRM CPHRM AIM DSA Executive Vice President/Chief Risk Officer Western Litigation In January of 2008, I joined the ranks of sepsis survivors. I too was placed on a ventilator, given months of antibiotic and antif…
Guest Author: Susan A. Irick, MS, RN, ACNP-C Disease Manager for Pneumonia and Sepsis Northeast Georgia Medical Center Sepsis is a term I have heard my entire nursing career. It never had quantifiable significance to me until the past 3 years. Now, sep…
Author: CDC Division of Foodborne, Waterborne, and Environmental Diseases (DFWED) Wondering how antibiotic resistance in foodborne bacteria has changed over time? You’re in luck. With CDC’s new interactive tool, NARMS Now: Human Data, you can view trends in antibiotic resistance over the past two decades for four bacteria transmitted commonly through food: Campylobacter, E. coli
The latest CDC Vital Signs includes mathematical modeling that projects increases in drug-resistant infections and Clostridium difficile (C. difficile) without immediate, nationwide improvements in infection control and antibiotic prescribing. During the next five years, with investments, CDC’s efforts to combat C. difficile infections and antibiotic resistance under the National Strategy to Combat Antibiotic Resistant Bacteria,
The latest CDC Vital Signs includes mathematical modeling that projects increases in drug-resistant infections and Clostridium difficile (C. difficile) without immediate, nationwide improvements in infection control and antibiotic prescribing. During the next five years, with investments, CDC’s efforts to combat C. difficile infections and antibiotic resistance under the National Strategy to Combat Antibiotic Resistant Bacteria,
The latest CDC Vital Signs includes mathematical modeling that projects increases in drug-resistant infections and Clostridium difficile (C. difficile) without immediate, nationwide improvements in infection control and antibiotic prescribing. During the next five years, with investments, CDC’s efforts to combat C. difficile infections and antibiotic resistance under the National Strategy to Combat Antibiotic Resistant Bacteria,
CDC’s Dr. Scott Fridkin Senior Advisor for Antibiotic Resistance in Health care Today CDC released its latest Vital Signs report, which includes mathematical modeling that projects increases in drug-resistant infections and Clostridium difficile (C. difficile) without immediate, nationwide improvements in infection control and antibiotic prescribing. The report includes recommendations that would impact how health care
Consumer Reports looks at how well hospitals prevent common infections A new analysis finds big differences in hospital performance against C. diff and MRSA infections An estimated one in 25 patients develops at least one infection while in the hospita…
Guest Author: Michele E. Gaguski MSN RN AOCN CHPN APN-C As an oncology nurse, I see the quick pace in which cancer treatment modalities continue to advance. I attribute this rapid advancement to several factors: new medications have gained approval c…
Guest Author: Dr. Evelyn McKnight, President and Co-Founder of HONOReform How thrilling to be part of a global effort to advance injection safety! It was a rewarding moment when we entered the doors of the World Health Organization in Geneva, Switzerla…
Guest Author: Sally M. Hess, CIC, MPH Manager, Infection Prevention, University of Vermont Medical Center Chair, APIC 2015 Annual Conference Committee AAhh…..It’s the time of year here in New England that I anticipate the coming of warmer days; we are finally seeing green leaves and flowers! It’s also the time of year I start getting